chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Since this summer, my periods cycle are getting shorter and shorter.  Instead of 28 days cycle, I have now less than 20 days. I couldn't understand why was this happening, but  after talking to other woman, I am pretty sure that is a side effect of vaccines.  It started gradually and it's getting worse.  I haven't visit a doctor yet, I am trying some vitamins and collagen for now.  If nothing will help, I would go to see a doctor.
This spontaneous report as received from a licensed practical nurse reporting on a patient of unknown age and gender who on an unspecified date was vaccinated with an expired dose of GARDASIL (lot# not reported, exp June/July 2012). No other co-suspects were reported. No concomitant medications were reported. No adverse reaction was reported. Additional information has been requested.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 28-JUN-2016, the patient was inadvertently administered with M-M-R II, subcutaneously (dose, frequency and lot information were unspecified for both vaccines) that were improperly stored (incorrect product storage). No adverse effect reported. The outcome of the events was unknown. This is one of the several reports received from the same reporter. Additional information has been requested.
Graves disease; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 27Mar2021 (Lot number: EP6955) at the age of 60 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Metal substances, aluminum, nickel, cobalt" (unspecified if ongoing), notes: Known allergies: Metal substances, aluminum, nickel, cobalt; "Degenerative disc disease" (unspecified if ongoing); "Degenerative disc disease, lumbar and cervical" (unspecified if ongoing); "Degenerative disc disease, lumbar and cervical" (unspecified if ongoing); "small bowel obstructions" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6203, Location of injection: Arm Left), administration date: 06Mar2021, when the patient was 60 years old, for COVID-19 Immunization. The following information was reported: BASEDOW'S DISEASE (disability) with onset 01Apr2021, outcome "not recovered", described as "Graves disease". The event "graves disease" was evaluated at the physician office visit. Therapeutic measures were taken as a result of basedow's disease. The patient did not have COIVD prior vaccination and was not COVID tested post vaccination.
Patient received a ZOSTAVAX on 11/12/13. A few days later she developed shingle-like rashes on her scalp and forehead. She was treated w/ VALTREX.
4 patients adult patients were administered booster shots with the pediatric formulation; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of INCORRECT DOSE ADMINISTERED (4 patients adult patients were administered booster shots with the pediatric formulation) and NO ADVERSE EVENT (No adverse event) in a 77-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 064A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On an unknown date, the patient experienced INCORRECT DOSE ADMINISTERED (4 patients adult patients were administered booster shots with the pediatric formulation) and NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (4 patients adult patients were administered booster shots with the pediatric formulation) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INCORRECT DOSE ADMINISTERED (4 patients adult patients were administered booster shots with the pediatric formulation).    No concomitant medication were provided.  Patient was expecting to get the bivalent booster (dose 5).  It was reported that the patient received the pediatric formulation of 0.5 mL as their booster doses (Lot 064A22A, Expiration date: 25SEP2022), instead of the Moderna COVID-19 vaccine, bivalent.   Patient have not reported any adverse reactions at this time.  No treatment details were provided   This case was linked to US-MODERNATX, INC.-MOD-2022-644023 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-644023:same reporter
This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapy were not reported. On 15-SEP-2016, the patient was vaccinated with an expired dose of PROQUAD (therapy type: human serum albumin), lot # L008353, expiration date 11-SEP-2016 (dose and route of administration were not reported). No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
4th day headache, brain fog, diarrhea, stomach pain, nausea  5th day dizzy, very dizzy, all day
caused her back problems to go away.; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer-sponsored program.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single; and dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced after receiving both of her doses all her symptoms have gone away (also reported she wanted to know what was in the vaccine that might have caused her back problems go away). The outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
At 1455 client  had a vasovagal syncopal reaction following 1st dose of Pfizer vaccine. Client stated he had a history of syncope and anxiety  with injections and blood draws. No injuries were sustained and client regained consciousness with sternal rub and verbal prompts. Client was unconscious for less than 20 seconds. Vital signs were obtained and were within normal limits. Client denied shortness of breath, headache, nausea, vomiting, diarrhea, dizziness or blurry vision. Client's pupils were PERRLA. Client complained of feeling stiffness and cramping in hands and arms. Paramedic was able to flex hands and arms without resistance, capillary refill was less than 2 seconds. Client offered 911 evaluation and declined three times. Client left via wheelchair and released to care of significant other following a 60 minute observation time and stated resolution of symptoms.
[MODERNA COVID VACCINE] treatment under Emergency Use Authorization(EUA):MODERNA COVID VACCINE With second injection patient became very impulsive, and erratic. Dissociative fugue state. Changes in judgement and delusions. Possible neuropsychiatric side effects from the vaccination, which seems perfectly reasonable given potential for severe neuropsychiatric sequelae from actual COVID infection. Drug should possibly include this warning,
COVID-19; COVID-19; This is a solicited report based on the information received by Pfizer from AbbVie Inc. (MFR Control No. #21K-163-4072551-00). A contactable consumer(patient) reported a 48-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), intramuscular on an unspecified date (at unknown age) as single dose for COVID-19 immunization; adalimumab (HUMIRA), subcutaneous from 14Aug2021 to 30Aug2021, at unspecified dose for moderate to severe adult crohn's disease. Medical history included moderate to severe adult crohn's disease. The patient's concomitant medications were not reported. The patient was with an event of non-serious CAUGHT COVID with HUMIRA (ADALIMUMAB). In Aug2021, the patient experienced CAUGHT COVID. In 2021, the caught COVID resolved. PFIZER BIONTECH COVID-19 VACCINE (TOZINAMERAN) was also considered suspect. It was unknown if patient was enrolled in a Covid-19 Vaccine Trial. On an unknown date, patient received Covid-19 Vaccine manufactured by Pfizer. Causality for HUMIRA(ADALIMUMAB): The reporter's causality for the event(s) of CAUGHT COVID with HUMIRA(ADALIMUMAB) was no reasonable possibility. Causality for COVID-19 as per reporter (Drug/Vaccine): Possible. The patient underwent lab tests and procedures which included Covid-19: positive on Aug2021. The action taken in response to the events for adalimumab was unknown. The outcome of the events was recovered in 2021.  The lot number for BNT162b2 was not provided and will be requested during follow up.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported drug ineffective and COVID-19 cannot be ruled out.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 09-APR-2015, the patient was vaccinated with improperly stored VARIVAX (Merck) lot # J013728, expiration date 30-OCT-2015 (dose and route were not reported). No adverse symptoms reported. No co-suspect and concomitant therapies were reported. This is one of several reports from the same source. Additional information has been requested.
Local reaction: Induration with erythema 9 cm x 8 cm approximately 5 cm below injection site.  Swelling present with increased local heat. Afebrile. Treated with ice packs and Tylenol with moderate relief.  At this time patient reports arm continues to be sore when touched and when used. Induration has dissipated. Erythema and swelling are almost resolved.
Shuffling while walking. Struggle with writing and his handwriting got smaller and shakier for the past two days.
Headache, Myalgia, Fever, L arm soreness, lump under skin, cold on the 3rd, arm pain, Narrative:
Pt recv vax on 10/23/98; on same day pt exp achiness,chills,temp,shivers &vomited 2x.
Hard swollen lymph node at the base of the left side of neck. Swollen to the size of a walnut.; painful  lymph node at the base of the left side of neck.; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0171) via an unspecified route of administration in the left arm on an unknown date in Apr2021 at 8:30, (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have allergies to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021 at 12:00, the patient experienced hard, painful swollen lymph node at the base of the left side of neck. It was swollen to the size of a walnut. No therapeutic measures were taken as a result of the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph node and pain lymph nodes was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a elderly male patient who received Shingrix for prophylaxis. On 31st July 2018, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was not recovered/not resolved. It was unknown if the reporter considered the shingles to be related to Shingrix. Additional details were provided as follows: The healthcare professional (HCP) reported that the patient developed a case of shingles. The HCP did not have lot number or expiry date.
October 21 - I began feeling pain and heat within a few hours of receiving the shot. I iced the area and took an Advil. As the night wore on the pain increased. I could not lay on my left side. I was not able to get any rest. October 22 - By morning, the pain and swelling had increased. I repeated the measures taken the night before.  I re-read the flyer given me by the nurse and saw that although rare, this was probably one of the more rare reactions.  By late morning  my arm, upper back and shoulder were on fire.  There was a distinct line between my upper arm and the area below my elbow.  It almost looked like someone had put a rubberband around my arm the color differences were so vast and the swelling so pronounced. The swelling above the elbow was substantial.  I propped up that side on pillows, took Advil, and hoped to get rest. I had this shot last fall and encountered nothing like this! October 23 - Yesterday the circle around my arm just up from the elbow joint was still present.  The redness was beginning to abate a little. There was still moderate pain and stiffness but nothing like the day before.  I notified my doctor and she told me to report this to you and gave me this website. October 24 - My arm is red and blotchy with little puffiness and swelling here and there. My shoulder is still a little sore but not bad.
Chills,  Elevated temp,  elevated heart rate ,  sore arm,  tired.
Swelling in the whole body; Especially the throat area, making it discomfort to swallow.; Stomach sick; pain in arm; brain fog.; This is a spontaneous report from a contactable consumer. This consumer reported for a male patient (son) that: A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Formulation; Solution for Injection, Batch/Lot Number: ER2613), dose 1 via an unspecified route of administration, administered in Arm Left on an unspecified date at 10:00 AM as dose 1, single for COVID-19 Immunization. Medical history included Wolff-Parkinson-White syndrome and essential tremor from an unknown date and unknown if ongoing and autism. Concomitant medication(s) included Ibuprofen (IBUPROFEN) 400 mg (each 200mgs x2 pills) taken for an unspecified indication, start and stop date were not reported. The patient previously received Morphine Batch/Lot number, and Expiry date was not provided) and experienced hives, Cefdinir Batch/Lot number, and Expiry date was not provided and experienced Pharyngeal swelling and Dysphagia. There was no other vaccine in four weeks. Patient did not have Covid prior vaccination. Patient did not Covid tested post vaccination. The patient experienced Swelling in the whole body, Especially the throat area, making it discomfort to swallow, Stomach sick, Pain in arm and Brain fog on 07Mar2021 12:00. No treatment was received for the events. The events were assessed as Non serious. The outcome of events recovered on an unspecified date in 2021.   No follow up attempts are possible; Information about lot/batch number cannot be requested. No further information is expected.
This spontaneous report as received from a consumer refers to his 4 week old (also reported as one month old) daughter. The patient was administered the Hepatitis A vaccine (injection, in the left leg), at an unspecified strength, in a pediatric office on 22-AUG-2013, instead of the Hepatitis B vaccine, which was the intended administration. The reporter was unable to confirm that the vaccine was VAQTA. Before leaving the office, the parents were informed of the error. The baby was able to go home with her parents. It was unspecified if the patient had sought medical attention. Additional information has been requested.
I had fatigue, fever overnight of 104, body ache.  I was very tired.  These symptoms went away in a few days. About 12 days later, I had emotional changes.  My emotional behavioral changes that my husband and sister notices. I did not notices that I was acting differently.   Then I got my flu shot.  This modified my symptoms.  I had weird pain in my foot and achiness all over.  I had mild itchy on my body.  On the three day, I had issues with balancing. On the four day, I had chest pain and SOB.  I went to the ER about.  They did a full cardio exam.
This is a prospective pregnancy case. This female subject was enrolled in an study. The subject received Flu Seasonal QIV .5 ml on an unknown date. The subject received Flu Seasonal QIV at week 23 of the pregnancy and during the second trimester of pregnancy. On an unknown date, an unknown time after receiving Flu Seasonal QIV the subject developed vaccine exposure during pregnancy (Non-serious). The outcome of vaccine exposure during pregnancy was unknown. The pregnancy was ongoing. The relationship of the vaccine exposure during pregnancy, vaccine exposure during pregnancy, vaccine exposure during pregnancy and vaccine exposure during pregnancy to treatment with Flu Seasonal QIV was not reported. Additional details provided: The estimated due date and date of last menstrual period are unknown.
lt arm soreness & warmth 1 day p/vax lasted 2 days; 5 days p/MMR afebrile tired body rash from neck to knees; itching, redness & jt redness;
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a consumer concerned a 28 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of administration was not reported, batch number: unknown and expiry: unknown) dose was not reported, 01 total administered on 29-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 14-DEC-2021, the patient tested positive for coronavirus disease (Covid-19) and had confirmed clinical vaccination failure. On the same date, he experienced fatigue, chills, fever, sore throat and leg muscle soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint. This case, from the same reporter is linked to 20211232994.; Sender's Comments: V0:20211232714-COVID-19 VACCINE AD26.COV2.S-Confirmed clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Site: Pain at Injection Site-Medium, Systemic: JOINT PAIN IN RIGHT THUMB , Error: Wrong Dose of Vaccine - Too High
Extreme, intense headaches and rise in blood pressure. However, the headaches would only occur if I left an upright, sitting position, either by standing or laying down. Upon standing, the headaches would occur after taking a few steps., and upon laying down, the headaches would occur after a few moments. The headaches were minimal if I remained in an upright sitting position. This occurred for several days. My blood pressure also spiked and I had to go to the emergency room. However, the headaches were NOT related to the high blood pressure, because my pressure was reduced in the emergency room, and immediately upon leaving the emergency room, after taking a few steps, the headaches returned. The headaches ended approximately 9 days after the second dose on May 11, 2021.
Pt reported itching and "red bumps" occurring  on the deltoid near the site of injection. These red bumps and itching remitted spontaneously.
Reported to have stiffness to left side of neck, slight headache, and feeling nauseated. Symptoms lasted about 5-6 hours.
Flu shot had no reaction, but pneumonia shot had a reaction. She had wheezing, chills, fever and was ill. Put on antibiotics from doctor. Injection given into the right arm.
Information has been received from a physician concerning a patient (age and geneder not identicated) was vaccinated with a dose of GARDASIL vaccine. The physician reported that the patient fainted after receiving the dose of GARDASIL vaccine. No further information about the AE available. The patient recovered "either on 25-JUL-2007 or 26-JUL-2007". This is in follow-up to report (s) previously submitted on 8/14/2007. Initial and follow up information has been received from a physician concerning a 18 year old female patient who on August 2007, was vaccinated IM in the deltoid with a dose of GARDASIL. The patient recovered. The physician reported that one other patient fainted after receiving a dose of GARDASIL vaccine. Additional information is not expected.